Please try another search
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cancer; and Phase IIa for the treatment of pancreatic cancer; as well as in Phase IIb trial for the treatment of metabolic associated steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops commercial predictive biomarker blood test kit for A3AR. It has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and collaboration agreement with Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. The company was incorporated in 1994 and is headquartered in Ramat Gan, Israel.
Name | Age | Since | Title |
---|---|---|---|
Pnina Fishman | 76 | 1994 | Founder, Chief Scientific Officer & Executive Chairperson |
Nabil Hanna | 80 | - | Member of Scientific Advisory Board |
Ilan Cohn | 70 | 1994 | Co-Founder & Director |
Yaacov Goldman | 69 | 2017 | External Independent Director |
Guy Regev | 55 | 2011 | Independent External Director |
Scott L. Friedman | - | - | Member of Clinical Advisory Board |
Rifaat Safadi | - | - | Member of Clinical Advisory Board |
Arun J. Sanyal | - | - | Member of Clinical Advisory Board |
Stephen A. Harrison | - | 2023 | Member of Clinical Advisory Board & Consulting Chief Medical Officer |
Kim Papp | - | - | Member of Clinical Advisory Board |
Yoseph Bornstein | 65 | 2021 | Independent External Director |
Salomon Stemmer | - | - | Member of Clinical Advisory Board |
Ohad Etzion | - | - | Member of the Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review